Skip to Main Content
Table 4—

The impact of planned care and the DEMS on metabolic outcomes

Metabolic outcomesMean change (95% CI)
BaselineDifference between index years (effect of planned care)Difference at index year 2 between users and nonusers of DEMS (effect of DEMS)
Glycemic control    
 Last HbA1c 7.3 (4.2–16) −0.5 (−0.8 to −0.3) 0.01 (−0.3 to 0.4) 
Lipids (mmol/l)    
 Total cholesterol 5.3 (2.3–8.5) −0.3 (−5.0 to 1.7) −0.1 (−3.5 to 1.8) 
 LDL cholesterol 3.2 (0.9–6.5) −0.4 (−0.6 to −0.3) −0.1 (−3.0 to 1.8) 
 Triglycerides 2.1 (0.4–19) −0.2 (−0.5 to −0.01) 0.1 (−1.7 to 3.5) 
Blood pressure (mmHg)    
 Systolic blood pressure 140 (92–220) −0.1 (−3 to 2.6) −0.8 (−5.0 to 3.4) 
 Diastolic blood pressure 75 (40–110) 0.2 (−1.2 to 1.7) −0.6 (−2.4 to 1.1) 
Calculated coronary disease risk    
 Framingham coronary risk score 12 (−8 to 21) −1.0 (−2.0 to 0.0) −0.3 (−1.4 to 0.9) 
 10-year coronary risk (%) 23.3 (0.4–75.6) −4.8 (−7.9 to −1.8) −2.1 (−1.1 to 5.3) 
Metabolic outcomesMean change (95% CI)
BaselineDifference between index years (effect of planned care)Difference at index year 2 between users and nonusers of DEMS (effect of DEMS)
Glycemic control    
 Last HbA1c 7.3 (4.2–16) −0.5 (−0.8 to −0.3) 0.01 (−0.3 to 0.4) 
Lipids (mmol/l)    
 Total cholesterol 5.3 (2.3–8.5) −0.3 (−5.0 to 1.7) −0.1 (−3.5 to 1.8) 
 LDL cholesterol 3.2 (0.9–6.5) −0.4 (−0.6 to −0.3) −0.1 (−3.0 to 1.8) 
 Triglycerides 2.1 (0.4–19) −0.2 (−0.5 to −0.01) 0.1 (−1.7 to 3.5) 
Blood pressure (mmHg)    
 Systolic blood pressure 140 (92–220) −0.1 (−3 to 2.6) −0.8 (−5.0 to 3.4) 
 Diastolic blood pressure 75 (40–110) 0.2 (−1.2 to 1.7) −0.6 (−2.4 to 1.1) 
Calculated coronary disease risk    
 Framingham coronary risk score 12 (−8 to 21) −1.0 (−2.0 to 0.0) −0.3 (−1.4 to 0.9) 
 10-year coronary risk (%) 23.3 (0.4–75.6) −4.8 (−7.9 to −1.8) −2.1 (−1.1 to 5.3) 

Data are median (range), unless otherwise indicated.

Close Modal

or Create an Account

Close Modal
Close Modal